
Christopher Y. Kim
Examiner (ID: 18274)
| Most Active Art Unit | 1801 |
| Art Unit(s) | 1744, 2876, 1801, 1312 |
| Total Applications | 419 |
| Issued Applications | 342 |
| Pending Applications | 16 |
| Abandoned Applications | 61 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18436460
[patent_doc_number] => 20230183754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => SYSTEMS, METHODS, AND COMPOSITIONS FOR CORRECTION OF FRAMESHIFT MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 18/055718
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/055718 | Systems, methods, and compositions for correction of frameshift mutations | Nov 14, 2022 | Issued |
Array
(
[id] => 18612727
[patent_doc_number] => 20230279461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => METHODS AND COMPOSITIONS FOR MAKING BACTERIOCINS AND ANTIMICROBIAL PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/052519
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052519
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052519 | Methods and compositions for making bacteriocins and antimicrobial peptides | Nov 2, 2022 | Issued |
Array
(
[id] => 19001192
[patent_doc_number] => 20240065263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => Compositions, Methods, and Applications of a Synthetic Surfactant
[patent_app_type] => utility
[patent_app_number] => 18/048548
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048548
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048548 | Compositions, methods, and applications of a synthetic surfactant | Oct 20, 2022 | Issued |
Array
(
[id] => 19840345
[patent_doc_number] => 12252717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Modified helicases
[patent_app_type] => utility
[patent_app_number] => 18/047589
[patent_app_country] => US
[patent_app_date] => 2022-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 28
[patent_no_of_words] => 49053
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047589
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047589 | Modified helicases | Oct 17, 2022 | Issued |
Array
(
[id] => 18485207
[patent_doc_number] => 20230212535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => MODIFIED HELICASES
[patent_app_type] => utility
[patent_app_number] => 18/047019
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047019
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047019 | Modified helicases | Oct 16, 2022 | Issued |
Array
(
[id] => 18530294
[patent_doc_number] => 20230235364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHODS AND MEANS FOR GENETIC ALTERATION OF GENOMES UTILIZING DESIGNER DNA RECOMBINING ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/046066
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046066
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046066 | METHODS AND MEANS FOR GENETIC ALTERATION OF GENOMES UTILIZING DESIGNER DNA RECOMBINING ENZYMES | Oct 11, 2022 | Pending |
Array
(
[id] => 18530294
[patent_doc_number] => 20230235364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHODS AND MEANS FOR GENETIC ALTERATION OF GENOMES UTILIZING DESIGNER DNA RECOMBINING ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/046066
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046066
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046066 | METHODS AND MEANS FOR GENETIC ALTERATION OF GENOMES UTILIZING DESIGNER DNA RECOMBINING ENZYMES | Oct 11, 2022 | Pending |
Array
(
[id] => 18786400
[patent_doc_number] => 20230374499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => GENE KNOCKOUT OF VARIANT NRF2 FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/960224
[patent_app_country] => US
[patent_app_date] => 2022-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960224 | Gene knockout of variant NRF2 for treatment of cancer | Oct 4, 2022 | Issued |
Array
(
[id] => 18862295
[patent_doc_number] => 20230416731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => GENE KNOCKOUT OF VARIANT NRF2 FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/960210
[patent_app_country] => US
[patent_app_date] => 2022-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960210 | Gene knockout of variant NRF2 for treatment of cancer | Oct 4, 2022 | Issued |
Array
(
[id] => 20272250
[patent_doc_number] => 12442020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Materials and methods for treatment of pain related disorders
[patent_app_type] => utility
[patent_app_number] => 17/959089
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 42381
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959089 | Materials and methods for treatment of pain related disorders | Oct 2, 2022 | Issued |
Array
(
[id] => 20272250
[patent_doc_number] => 12442020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Materials and methods for treatment of pain related disorders
[patent_app_type] => utility
[patent_app_number] => 17/959089
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 42381
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959089 | Materials and methods for treatment of pain related disorders | Oct 2, 2022 | Issued |
Array
(
[id] => 18436476
[patent_doc_number] => 20230183770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Enzyme Based System for Production of Messenger RNA with Increased Transfection Efficiency
[patent_app_type] => utility
[patent_app_number] => 17/931352
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931352 | Enzyme based system for production of messenger RNA with increased transfection efficiency | Sep 11, 2022 | Issued |
Array
(
[id] => 18808932
[patent_doc_number] => 20230383267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => Flp-TAL RECOMBINASES
[patent_app_type] => utility
[patent_app_number] => 17/943127
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943127 | Flp-TAL recombinases | Sep 11, 2022 | Issued |
Array
(
[id] => 18436476
[patent_doc_number] => 20230183770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Enzyme Based System for Production of Messenger RNA with Increased Transfection Efficiency
[patent_app_type] => utility
[patent_app_number] => 17/931352
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931352 | Enzyme based system for production of messenger RNA with increased transfection efficiency | Sep 11, 2022 | Issued |
Array
(
[id] => 18342023
[patent_doc_number] => 11639499
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-02
[patent_title] => Reverse transcriptase variants
[patent_app_type] => utility
[patent_app_number] => 17/940797
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 13668
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940797 | Reverse transcriptase variants | Sep 7, 2022 | Issued |
Array
(
[id] => 18838561
[patent_doc_number] => 11846628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Organelle-targeted genetically-encoded voltage indicators and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/893530
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5613
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893530
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/893530 | Organelle-targeted genetically-encoded voltage indicators and methods of use thereof | Aug 22, 2022 | Issued |
Array
(
[id] => 18281902
[patent_doc_number] => 20230097374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Recombinant expression platform, constructs and methods for expression of Difficult to Express Proteins (DTE-Ps)
[patent_app_type] => utility
[patent_app_number] => 17/878657
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/878657 | Recombinant expression platform, constructs and methods for expression of Difficult to Express Proteins (DTE-Ps) | Jul 31, 2022 | Pending |
Array
(
[id] => 18022062
[patent_doc_number] => 20220373561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => TRANSFORMATIONAL IMMUNE DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 17/816637
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816637 | TRANSFORMATIONAL IMMUNE DIAGNOSTICS | Jul 31, 2022 | Pending |
Array
(
[id] => 19397290
[patent_doc_number] => 12071641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => RNA-guided nucleases and DNA binding proteins
[patent_app_type] => utility
[patent_app_number] => 17/815453
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 40852
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 640
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815453 | RNA-guided nucleases and DNA binding proteins | Jul 26, 2022 | Issued |
Array
(
[id] => 19258265
[patent_doc_number] => 12018311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Long chain dibasic acid with low content of long chain dibasic acid impurity of shorter carbon-chain and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/814972
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12641
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814972 | Long chain dibasic acid with low content of long chain dibasic acid impurity of shorter carbon-chain and preparation method thereof | Jul 25, 2022 | Issued |